Developing a new medical/cosmetic device whose technology is already classified by the FDA vs. developing a device with novel technology can have different development pathways and timelines. These pathways and how the device could be classified under the FDA system of classification (e.g. class I , II, III) will be discussed during an October 11 webinar developed by the Independent Cosmetic Manufacturers and Distributors (ICMAD).    The implications of being given a certain classific...